("Talus Bio"), an AI-native therapeutics company, today released Ptarmigan-1, the first structure-free model that can accurately predict small molecule binding sites across the entire human proteome, ...

Internal benchmarks show that Ptarmigan-1 can run 5,000x faster than structure-based methods and screen over three billion compounds in a day.

These plans provide the necessary details and definitions for design and construction of the structure-free zone for a fish passable structure. The Structure-Free Zone (SFZ) plans may be used when ...

Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...